Veeco Appoints Gordon Hunter to Board of Directors
June 14, 2010
PLAINVIEW, N.Y.--Veeco Instruments Inc. (NASDAQ: VECO - News) announced that Gordon Hunter has been appointed to its Board of Directors. Mr. Hunter, age 58, currently serves as Chairman, President and Chief Executive Officer of Littelfuse, Inc. (NASDAQ: LFUS - News), a provider of circuit protection products and solutions with annual sales of $430 million in [...]
Mark McGowan Appointed Interim CEO of CombiMatrix, Effective July 1, 2010
June 14, 2010
MUKILTEO, Wash. -- -- CombiMatrix Corporation (Nasdaq:CBMX) announced today that its Board of Directors has appointed Mark McGowan to the role of Interim President and Chief Executive Officer, effective July 1, 2010 upon the transition from current President and CEO, Dr. Amit Kumar. Dr. Amit Kumar stated, "As we had previously announced, I plan to [...]
MP Biomedicals Acquires New Zealand Protein Biologics Company
June 14, 2010
SANTA ANA, Calif.--MP Biomedicals LLC announced today that it has signed a definitive agreement to acquire the assets of ICPbio International LTD., an Auckland, New Zealand based protein biologics manufacturing company, subject to normal closing adjustments. This acquisition places MP Biomedicals in a strong position to pursue sales and distribution of serum protein products used [...]
genOway Improves its Growth With Major Japanese Biopharmaceutical Companies
June 14, 2010
Lyon (France) -- genOway (ALTERNEXT-NYSE EURONEXT: ALGEN; ISIN: FR0004053510), the biotechnology company dedicated to the development of genetically modified animal models, today announces strong growth of its business with major Japanese biopharmaceutical companies. The three Japanese biopharmaceutical companies, now customers of genOway, rank among the top ten of the nation’s biopharmaceutical industry. The amount of [...]
June 14, 2010
SAN JOSE, Calif. -- Thermo Fisher Scientific Inc., the world leader in serving science, announces the extension of its LC-MS ion trap and triple stage quadrupole trade-in programs to include the trade-in of instruments from any vendor. Scientists are invited to participate in the Traps and Triples Trade-In Program by trading in ion trap or [...]
Cemtrex Sees Business Opportunities from EPA Ruling on Sulfur Dioxide
June 14, 2010
FARMINGDALE, N.Y. -- -- Cemtrex Inc. (OTC:CTEI.ob - News) is optimistic about business opportunities resulting from the recent Environmental Protection Agency's (EPA's) ruling that sets the one-hour SO2 health standard at 75 parts per billion (ppb), down from the current standard of 140 ppb, a level designed to protect against short-term exposures ranging from five [...]
Esco Announces NEW Generation of Best-Selling Labculture Class II Biological Safety Cabinets
June 14, 2010
Singapore -- Esco announces the release of NEW generation Labculture Class II Biological Safety Cabinets, the industry's most certified biosafety cabinet product line. New generation Labculture Class II Biological Safety Cabinets feature: All models standardized to lower height (1540mm or 60.6") Enhanced Sentinel Gold 4-line LCD graphical interface Improved User Interface, simplified Menu navigation New/simplified [...]
ABI Expands Distribution of Rapid Heparin Antibody Test With Fisher Healthcare
June 14, 2010
Akers Biosciences, Inc (AIM:AKR), a leading designer and manufacturer of rapid diagnostic screening and testing products, today announces a major distribution agreement with Fisher HealthCare for ABI’s PIFA® Heparin/PF4 Rapid Assay (PIFA HPF4) and related products. Fisher HealthCare is one of the USA’s leading healthcare product channels. The addition of Fisher HealthCare’s resources will expose [...]
ExonHit Signs an Exclusive Agreement with Genmab for Novel Splice Variant Targets in Breast Cancer
June 14, 2010
PARIS -- -- Regulatory News -- “This pilot study clearly demonstrates the ability of ExonHit’s technology to identify novel target candidates for breast cancer treatment approaches.” ExonHit applied its genome-wide SpliceArray™ technology to develop a unique database in breast cancer Genmab retains exclusive rights on 10 novel splice events to fuel its antibody discovery activity [...]
June 14, 2010
NEW YORK -- -- Amalgamated Capital (AmalCap), a recently formed division of Amalgamated Bank, announced today it served as Co-Lead Arranger for a $25 million senior secured credit facility in support of the acquisition of Wheaton Industries Inc. (Wheaton) by PNC Equity Partners II, L.P. AmalCap provides cash flow-based senior debt financing to support investments [...]

